| Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ... Hepatology 48 (3), 792-798, 2008 | 679 | 2008 |
| Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ... Hepatology 51 (4), 1209-1217, 2010 | 528 | 2010 |
| Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 517 | 2020 |
| Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ... Gastroenterology 122 (2), 274-280, 2002 | 389 | 2002 |
| Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association S Fargion, A Piperno, MD Cappellini, M Sampietro, AL Fracanzani, ... Hepatology 16 (6), 1322-1326, 1992 | 369 | 1992 |
| Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 346 | 2015 |
| Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ... American Journal of Gastroenterology 102 (6), 1251-1258, 2007 | 295 | 2007 |
| Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis S Fargion, M Mattioli, AL Fracanzani, M Sampietro, D Tavazzi, P Fociani, ... The American journal of gastroenterology 96 (8), 2448-2455, 2001 | 293 | 2001 |
| Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target P Dongiovanni, AL Fracanzani, S Fargion, L Valenti Journal of hepatology 55 (4), 920-932, 2011 | 286 | 2011 |
| Carotid artery intima-media thickness in nonalcoholic fatty liver disease AL Fracanzani, L Burdick, S Raselli, P Pedotti, L Grigore, G Santorelli, ... The American journal of medicine 121 (1), 72-78, 2008 | 266 | 2008 |
| Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ... Hepatology 53 (3), 791-799, 2011 | 259 | 2011 |
| Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease AL Fracanzani, D Conte, M Fraquelli, E Taioli, M Mattioli, A Losco, ... Hepatology 33 (3), 647-651, 2001 | 259 | 2001 |
| HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ... Gastroenterology 138 (3), 905-912, 2010 | 248 | 2010 |
| Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis S Fargion, C Mandelli, A Piperno, B Cesana, AL Fracanzani, M Fraquelli, ... Hepatology 15 (4), 655-659, 1992 | 238 | 1992 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 232 | 2019 |
| Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development M Borzio, S Fargion, F Borzio, AL Fracanzani, AM Croce, T Stroffolini, ... Journal of hepatology 39 (2), 208-214, 2003 | 228 | 2003 |
| High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda M Sampietro, A Piperno, L Lupica, C Arosio, A Vergani, N Corbetta, ... Hepatology 27 (1), 181-184, 1998 | 220 | 1998 |
| Nonalcoholic fatty liver disease and vascular disease: state-of-the-art S Fargion, M Porzio, AL Fracanzani World Journal of Gastroenterology: WJG 20 (37), 13306, 2014 | 186 | 2014 |
| Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease P Dongiovanni, L Valenti, R Rametta, AK Daly, V Nobili, E Mozzi, ... Gut 59 (2), 267-273, 2010 | 176 | 2010 |
| Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis L Valenti, R Rametta, P Dongiovanni, M Maggioni, AL Fracanzani, ... Diabetes 57 (5), 1355-1362, 2008 | 160 | 2008 |
